Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1980-10-27
|
pubmed:abstractText |
Thirty-six women with sustained hyperprolactinaemia, 29 showing radiological abnormality of the pituitary fossa, were managed conservatively; 28 accepted bromocriptine treatment which controlled hyperprolactinaemia in all and was associated with improvement in the radiological appearance of the pituitary in 4 cases. Two of the 8 patients who did not accept bromocriptine showed radiological extension of the pituitary lesion; one showed radiological improvement. Bromocriptine should be regarded as a drug to control the pituitary tumour, not merely one which inhibits the endocrine effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0306-5456
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
523-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7397087-Adult,
pubmed-meshheading:7397087-Amenorrhea,
pubmed-meshheading:7397087-Bromocriptine,
pubmed-meshheading:7397087-Female,
pubmed-meshheading:7397087-Humans,
pubmed-meshheading:7397087-Menstruation,
pubmed-meshheading:7397087-Middle Aged,
pubmed-meshheading:7397087-Pituitary Neoplasms,
pubmed-meshheading:7397087-Pregnancy,
pubmed-meshheading:7397087-Prolactin,
pubmed-meshheading:7397087-Visual Fields
|
pubmed:year |
1980
|
pubmed:articleTitle |
Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
|
pubmed:publicationType |
Journal Article
|